BIOMAT Database Logo BIOMAT Database Logo

Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. 2006

A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Department of Pediatrics, University of Colorado at Denver and Health Sciences Center, Denver, CO 80045, USA.

Mer (MerTK) is a receptor tyrosine kinase important in platelet aggregation, as well as macrophage cytokine secretion and clearance of apoptotic cells. Mer is not normally expressed in thymocytes or lymphocytes; however, ectopic Mer RNA transcript and protein expression is found in a subset of acute lymphoblastic leukemia cell lines and patient samples, suggesting a role in leukemogenesis. To investigate the oncogenic potential of Mer in vivo, we created a transgenic mouse line (Mer(Tg)) that expresses Mer in the hematopoietic lineage under control of the Vav promoter. Ectopic expression and activation of the transgenic Mer protein was demonstrated in lymphocytes and thymocytes of the Mer(Tg) mice. At 12-24 months of age, greater than 55% of the Mer(Tg) mice, compared to 12% of the wild type, developed adenopathy, hepatosplenomegaly, and circulating lymphoblasts. Histopathological analysis and flow cytometry were consistent with T-cell lymphoblastic leukemia/lymphoma. Mer may contribute to leukemogenesis by activation of Akt and ERK1/2 anti-apoptotic signals, which were upregulated in Mer(Tg) mice. Additionally, a significant survival advantage was noted in Mer(Tg) lymphocytes compared to wild-type lymphocytes after dexamethasone treatment. These data suggest that Mer plays a cooperative role in leukemogenesis and may be an effective target for biologically based leukemia/lymphoma therapy.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076202 c-Mer Tyrosine Kinase A receptor tyrosine kinase that transduces signals from EXTRACELLULAR MATRIX to the CYTOPLASM by binding ligands such as GALECTIN 3. It regulates many physiologic processes that include cell survival, migration, differentiation, and PHAGOCYTOSIS of apoptotic cells and ROD PHOTORECEPTORS in the RETINAL PIGMENT EPITHELIUM. Mutations in the MERTK gene are associated with type 38 RETINITIS PIGMENTOSA; it also plays a critical role as an inhibitor of TOLL-LIKE RECEPTORS signaling. MERTK,c-Mer Proto-Oncogene Tyrosine Kinase,Kinase, c-Mer Tyrosine,Tyrosine Kinase, c-Mer,c Mer Proto Oncogene Tyrosine Kinase,c Mer Tyrosine Kinase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015458 Leukemia, T-Cell A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood. Leukemia, Lymphocytic, T-Cell,Lymphocytic Leukemia, T-Cell,T-Cell Leukemia,T-Lymphocytic Leukemia,Leukemia, Lymphocytic, T Cell,T Lymphocytic Leukemia,Leukemia, T Cell,Leukemia, T Lymphocytic,Leukemia, T-Cell Lymphocytic,Leukemia, T-Lymphocytic,Leukemias, T Lymphocytic,Leukemias, T-Cell,Leukemias, T-Cell Lymphocytic,Leukemias, T-Lymphocytic,Lymphocytic Leukemia, T,Lymphocytic Leukemia, T Cell,Lymphocytic Leukemias, T,Lymphocytic Leukemias, T-Cell,T Cell Leukemia,T Lymphocytic Leukemias,T-Cell Leukemias,T-Cell Lymphocytic Leukemia,T-Cell Lymphocytic Leukemias,T-Lymphocytic Leukemias

Related Publications

A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.
August 2013, Blood,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.
September 2009, Blood,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.
July 2009, Journal of leukocyte biology,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development.
January 2022, Frontiers in immunology,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
November 2013, Oncogene,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
December 2016, Oncogene,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Receptor MER Tyrosine Kinase Proto-oncogene (MERTK) Is Not Required for Transfer of Bis-retinoids to the Retinal Pigmented Epithelium.
December 2016, The Journal of biological chemistry,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
May 2013, The Journal of clinical investigation,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Retinitis pigmentosa: mutations in a receptor tyrosine kinase gene, MERTK.
March 2001, Journal of biosciences,
A K Keating, and D B Salzberg, and S Sather, and X Liang, and S Nickoloff, and A Anwar, and D Deryckere, and K Hill, and D Joung, and K K Sawczyn, and J Park, and D Curran-Everett, and L McGavran, and L Meltesen, and L Gore, and G L Johnson, and D K Graham
Phosphorylation of Ack1 by the Receptor Tyrosine Kinase Mer.
September 2023, Kinases and phosphatases,
Copied contents to your clipboard!